CAS: 319460-94-1
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | AG-13958 REF: 7W-GW6755CAS: 319460-94-1 | - - - | 619.00 €~1,746.00 € | Tue 10 Dec 24 |
 | AG-13958 REF: TM-T7493CAS: 319460-94-1 | 99.40% | 94.00 €~1,220.00 € | Tue 10 Dec 24 |
 | AG 13958 REF: 3D-FA103515CAS: 319460-94-1 | Min. 95% | To inquire | Tue 14 Jan 25 |
Ref: 7W-GW6755
| 1mg | 619.00 € | ||
| 5mg | 1,147.00 € | ||
| 10mg | 1,746.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
AG-13958
CAS:319460-94-1
AG-13958 (AG-013958) (AG-013958), a potent VEGFR tyrosine kinase inhibitor, for the treatment of age-related macular …
Formula:
C26H22FN7O
Purity:
99.40%
Color and Shape:
Solid
Molecular weight:
467.5
Ref: TM-T7493
| 1mg | 94.00 € | ||
| 5mg | 257.00 € | ||
| 10mg | 396.00 € | ||
| 25mg | 637.00 € | ||
| 50mg | 918.00 € | ||
| 100mg | 1,220.00 € | ||
| 1mL*10mM (DMSO) | 268.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
AG 13958
CAS:319460-94-1
AG 13958 is a biological product that is used to treat age-related macular degeneration. It …
Formula:
C26H22FN7O
Purity:
Min. 95%
Molecular weight:
467.5 g/mol
Ref: 3D-FA103515
| 1mg | To inquire | ||
| 2mg | To inquire | ||
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire |
Estimated delivery in United States, on Tuesday 14 Jan 2025
